Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04742309 · ClinicalTrials.gov registry record · Phase 4
Pectoralis Block vs Paravertebral Nerve Blocks for Breast Surgery
A Phase 4 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 119
- Enrollment target
NCT04742309 is a Phase 4 study that has completed, run by University of California, San Diego. The registered enrollment target is 119 participants.
The verdict
NCT04742309, a Phase 4 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 119 participants
- Enrollment target
Study Summary
Following painful surgical procedures of the breast, postoperative analgesia is often provided with a nerve block called a "paravertebral" block. For intense, but shorter-duration acute pain, a single-injection of numbing medicine is used which lasts about 12 hours. Recently, a new type of block has been reported: the "Pecs-2" block. The theoretical benefits include ease of administration since it is closer to the skin (less deep) compared with the paravertebral block and therefore easier to identify and target with ultrasound (therefore increasing success rate); and, a lower risk of complications. Lastly, it might be easier to insert a tiny tube which would allow additional numbing medicine to be injected. There are, therefore, multiple theoretical reasons to prefer the Pecs-2 over the paravertebral nerve block. Unfortunately, it remains unknown if the pain control provided by this new type of block is comparable to that provided with the older block. The investigators therefore propose to compare these two blocks with a clinical study.
Interventions
- DRUG Paravertebral block (single injection)
- DRUG Pecs-2 block (single injection)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2021-02-25 |
| Est. Completion | 2023-08-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04742309
The ClinicalTrials.gov registry entry for NCT04742309 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Paravertebral block (single injection) is the first listed.
NCT04742309 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04742309 about?
NCT04742309 is a clinical study titled "Pectoralis Block vs Paravertebral Nerve Blocks for Breast Surgery". Following painful surgical procedures of the breast, postoperative analgesia is often provided with a nerve block called a "paravertebral" block. For intense, but shorter-duration acute pain, a single-injection of numbing medicine is used which lasts about 12 hours. Recently, a new type of block has...
What is the current status of trial NCT04742309?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 119 participants. The study started on 2021-02-25. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT04742309?
The interventions under investigation include: Paravertebral block (single injection) (DRUG), Pecs-2 block (single injection) (DRUG).
Who is sponsoring clinical trial NCT04742309?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.